ROCKET LAB USA INC. - COMMON STOCK
28.84
10-February-25 10:11:59
15 minutes delayed
Stocks
+1.43
+5.22%
Today's range
27.36 - 29.14
ISIN
N/A
Source
NASDAQ
-
Truist Financial Forecasts Strong Price Appreciation for Berry Global Group (NYSE:BERY) Stock
10 Feb 2025 09:31:10 By Buzz FX
-
Truist Financial Issues Positive Forecast for Camping World (NYSE:CWH) Stock Price
10 Feb 2025 09:31:10 By Buzz FX
-
Suncor Energy (NYSE:SU) Raised to "Buy" at Tudor, Pickering, Holt & Co.
10 Feb 2025 09:31:10 By Buzz FX
-
Barclays Cuts 10x Genomics (NASDAQ:TXG) Price Target to $18.00
10 Feb 2025 09:31:10 By Buzz FX
-
Jayakumar Rajarathinam Sells 40,000 Shares of TMX Group Limited (TSE:X) Stock
10 Feb 2025 09:31:10 By Buzz FX
-
Pliant Therapeutics (NASDAQ:PLRX) Downgraded to "Neutral" Rating by JPMorgan Chase & Co.
10 Feb 2025 09:31:10 By Buzz FX
-
Pfizer (NYSE:PFE) Earns Buy Rating from Guggenheim
10 Feb 2025 09:31:10 By Buzz FX
-
Pliant Therapeutics' (PLRX) "Market Perform" Rating Reaffirmed at Oppenheimer
10 Feb 2025 09:27:11 By Buzz FX
-
Bank of America Begins Coverage on Capri (NYSE:CPRI)
10 Feb 2025 09:27:11 By Buzz FX
-
Equitable (NYSE:EQH) Price Target Raised to $60.00 at Truist Financial
10 Feb 2025 09:26:10 By Buzz FX
-
Truist Financial Lowers Flowers Foods (NYSE:FLO) Price Target to $20.00
10 Feb 2025 09:26:10 By Buzz FX
-
Barclays Lowers Bruker (NASDAQ:BRKR) Price Target to $65.00
10 Feb 2025 09:26:10 By Buzz FX
-
Guggenheim Reiterates "Buy" Rating for ORIC Pharmaceuticals (NASDAQ:ORIC)
10 Feb 2025 09:26:10 By Buzz FX
-
Truist Financial Reaffirms Buy Rating for IQVIA (NYSE:IQV)
10 Feb 2025 09:26:10 By Buzz FX
-
Eversource Energy (NYSE:ES) Receives "Buy" Rating from Guggenheim
10 Feb 2025 09:26:10 By Buzz FX
-
Centessa Pharmaceuticals (NASDAQ:CNTA) Given Buy Rating at Guggenheim
10 Feb 2025 09:26:10 By Buzz FX
-
Aspen Technology (NASDAQ:AZPN) Raised to Buy at Loop Capital
10 Feb 2025 09:26:10 By Buzz FX
-
Skyworks Solutions (NASDAQ:SWKS) Stock Rating Lowered by Argus
10 Feb 2025 09:26:10 By Buzz FX
-
Guggenheim Lowers Neurocrine Biosciences (NASDAQ:NBIX) Price Target to $163.00
10 Feb 2025 09:26:10 By Buzz FX